HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SlimAmerica permanent injunction

This article was originally published in The Tan Sheet

Executive Summary

Firm ordered to pay Federal Trade Commission $8.4 mil. under permanent injunction issued by a Miami federal court judge in a false advertising case, FTC announces July 19. The agency filed suit in January 1997 (1"The Tan Sheet" Feb. 10, 1997, p. 24). Claims made for the company's three-product Super Formula line include "blast up to 49 pounds off you in only 29 days!" Co-defendant Frank Sarcone is ordered to post a $5 mil. "performance bond" before conducting "business related to weight-loss products or services specifically, or...marketing of any product or services generally, anywhere in the United States"; co-defendant Robert Wyman must post a bond of $1 mil. The court declares Sarcone's transfer of funds to a Bahamian bank "null and void" and the receiver for the case is ordered to "effectuate a repatriation of these assets." The order was issued June 30

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140600

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel